Tran Sophie, Pullano Kerry J, Henry Sharon, Ribeiro Marcelo A F
School of Medicine, University of Maryland, Baltimore, MD 21201, USA.
R Adams Cowley Shock Trauma Center, University of Maryland, Baltimore, MD 21201, USA.
J Clin Med. 2025 Jun 26;14(13):4550. doi: 10.3390/jcm14134550.
Necrotizing soft tissue infections (NSTIs) remain a significant source of in-hospital morbidity and mortality in the U.S. and around the world, yet the need for a reliable tool to assess prognosis early in treatment remains unaddressed in the current medical literature. Many scoring systems have been developed; however, none have proven to be entirely reliable for use in patients with NSTIs. Using collected data through a PubMed and Google Scholar search, this review provides an overview of five scoring systems-LRINEC, platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), NECROSIS, and POTTER-while highlighting potential areas for further improvement of these scoring systems or the conception of a novel, more effective system. The most widely used scoring tool, the Laboratory Risk Indicator for Necrotizing Fasciitis Score (LRINEC), lacks high sensitivity and requires supplementation of other clinical parameters. The NECROSIS score offers a potentially improved system, though it lacks necessary external validation. NLR and PLR provide reliable measurements for immune response; however, they lack specificity for NSTI and require further research to determine parameters like cutoff values. The POTTER score, though not valid for use in patients with NSTI, poses a novel system utilizing AI technology and machine learning. This review concludes that further development of a reliable scoring system that accounts for the many factors involved in NSTI is required and may benefit from an integrative model like the POTTER score.
坏死性软组织感染(NSTIs)在美国乃至全球仍然是院内发病和死亡的重要原因,然而目前医学文献中尚未解决早期治疗中评估预后的可靠工具的需求问题。已经开发了许多评分系统;然而,没有一个被证明对NSTIs患者完全可靠。通过PubMed和谷歌学术搜索收集的数据,本综述概述了五个评分系统——LRINEC、血小板与淋巴细胞比率(PLR)、中性粒细胞与淋巴细胞比率(NLR)、NECROSIS和POTTER——同时强调了这些评分系统进一步改进或构思一种新颖、更有效的系统的潜在领域。最广泛使用的评分工具——坏死性筋膜炎实验室风险指标评分(LRINEC)——缺乏高敏感性,需要补充其他临床参数。NECROSIS评分提供了一个可能改进的系统,尽管它缺乏必要的外部验证。NLR和PLR为免疫反应提供了可靠的测量;然而,它们对NSTI缺乏特异性,需要进一步研究来确定临界值等参数。POTTER评分虽然对NSTI患者无效,但提出了一种利用人工智能技术和机器学习的新颖系统。本综述得出结论,需要进一步开发一个可靠的评分系统,该系统要考虑到NSTI涉及的许多因素,并且可能受益于像POTTER评分这样的综合模型。